Status:
COMPLETED
Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor
Lead Sponsor:
Tanta University
Conditions:
Epidural Analgesia
Painless Labor
Eligibility:
All Genders
21-41 years
Phase:
PHASE4
Brief Summary
Central neuraxial analgesia has been extensively used for labor analgesia and is currently the gold standard technique for pain control in obstetrics. The aim of the study will be to compare the role...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status class II and III,
- Full term pregnancy.
Exclusion
- Patient refusal to epidural analgesia,
- Contraindications of epidural analgesia (coagulopathy, local infection, vertebral deformity hypersensitivity to levobupivacaine, dexmedetomidine or fentanyl, hemodynamic instability, severe aortic or mitral stenosis),
- Cardiac diseases
- Severe pre-eclampsia,
- Breech presentations
- Antepartum hemorrhage
- Cephalopelvic disproportion
- Body mass index ≥40 kg/m2.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04397406
Start Date
July 1 2020
End Date
October 31 2021
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospitals
Tanta, Gharbia Governorate, Egypt, 31527